Organization Announcements

Organization Announcements

 

Paul G. Allen Frontiers Group [to 27 Feb 2021]
https://alleninstitute.org/what-we-do/frontiers-group/news-pr ess/
News
No new digest content identified.

 

BARDA – U.S. Department of HHS [to 27 Feb 2021]
https://www.phe.gov/about/barda/Pages/default.aspx
BARDA News
No new digest content identified.

 

BMGF – Gates Foundation [to 27 Feb 2021]
http://www.gatesfoundation.org/Media-Center/Press-Releases
Press Releases and Statements
No new digest content identified.

 

Bill & Melinda Gates Medical Research Institute [to 27 Feb 2021]
https://www.gatesmri.org/
The Bill & Melinda Gates Medical Research Institute is a non-profit biotech organization. Our mission is to develop products to fight malaria, tuberculosis, and diarrheal diseases—three major causes of mortality, poverty, and inequality in developing countries. The world has unprecedented scientific tools at its disposal; now is the time to use them to save the lives of the world’s poorest people
No new digest content identified.

 

CARB-X [to 27 Feb 2021]
https://carb-x.org/
News
02.22.2021  |
CARB-X is funding The University of Queensland to develop a new drug targeted to low- and middle-income countries that would breathe new life into existing readily-available antibiotics in the fight against drug-resistance
CARB-X is awarding up to US$2.2 million to The University of Queensland’s (UQ) Institute for Molecular Bioscience (IMB) to expand its Octapeptin research program to develop a new drug designed for use in low- and middle-income countries (LMICs) where there are high levels of drug-resistant bacteria.

 

Center for Vaccine Ethics and Policy – GE2P2 Global Foundation [to 27 Feb 2021]
https://centerforvaccineethicsandpolicy.net/
News/Analysis/Statements
Past weekly editions of Vaccines and Global Health: The Week in Review are available here.

 

CEPI – Coalition for Epidemic Preparedness Innovations [to 27 Feb 2021]
http://cepi.net/
Latest News
In the fight against novel COVID-19 variants, Norway and Germany provide vital additional funds to CEPI
The donations come at a critical time as CEPI works to advance vaccines against COVID-19 variants.
25 Feb 2021
Norway, one of the co-founders of CEPI, announced this week that it will contribute US $24 million (NOK 200 million) towards CEPI’s R&D efforts to future-proof vaccines against current and future variants of the SARS-CoV-2 virus.
The financial commitment follows the US $145 million (EUR 120 million) donation announced by the Government of Germany last week following the extraordinary G7 virtual summit to support CEPI’s COVID-19 vaccine programmes. The funding is as part of a wider US $1.82 billion (EUR 1.5 billion) donation package to partners of the Access to COVID-19 Tools (ACT) Accelerator.
These investments come at a critical time of the COVID-19 pandemic, with CEPI seeking to expand its efforts and respond to the rapidly evolving crisis…

COVID-19 vaccine doses shipped by the COVAX Facility head to Ghana, marking beginning of global rollout
600,000 doses of the AstraZeneca/Oxford vaccine licensed to Serum Institute of India have arrived in Accra, Ghana; further deliveries are expected this week.
24 Feb 2021

 

DARPA – Defense Advanced Research Projects Agency [to 27 Feb 2021
https://www.darpa.mil/
News
No new digest content identified.

Duke Global Health Innovation Center [to 27 Feb 2021]
https://dukeghic.org/
Launch and Scale Speedometer
No new digest content identified.

 

EDCTP [to 27 Feb 2021]
http://www.edctp.org/
The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials
25 February 2021
GHIT and EDCTP co-invest additional €7.8 million in access programme for treatment of schistosomiasis in preschool-aged children

 

Emory Vaccine Center [to 27 Feb 2021]
http://www.vaccines.emory.edu/
Vaccine Center News
No new digest content identified.

 

European Commission [to 27 Feb 2021]
http://europa.eu/rapid/search-result.htm?query=18&locale=en&page=1
Latest
News 26 February 2021
Von der Leyen at the video conference of the members of the European Council discusses vaccination, security and defence, and Southern Neighbourhood
To continue increasing the speed of our vaccination effort, she called on everyone to play a role. The Commission is working with the companies to ramp up production and address bottlenecks in the supply, she explained.

News 23 February 2021
President von der Leyen joins the Global Citizen campaign to end COVID-19 and kick start a global recovery
“We have to fight the pandemic right now, but we also have to address its broader impact on the most vulnerable and tackle the root causes,” said Ursula von der Leyen, President of the European Commission.

 

European Medicines Agency [to 27 Feb 2021]
http://www.ema.europa.eu/ema/
News & Press Releases
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 February 2021
CHMP, Last updated: 26/02/2021

 

 

News: Adapting COVID-19 vaccines to SARS-CoV-2 variants: guidance for vaccine manufacturers
CHMP, Last updated: 25/02/2021
EMA has issued guidance outlining the requirements for manufacturers planning to modify their COVID-19 vaccines in order to address coronavirus (SARS-CoV-2) variants.

Currently, three vaccines are authorised for use in the EU: ComirnatyCOVID-19 Vaccine Moderna and COVID-19 Vaccine AstraZeneca. Viruses typically mutate and several variant strains of SARS-CoV-2 have already been identified worldwide. The three authorised vaccines provide protection against the variants that are currently prevalent across Europe. However, it appears that with continued mutations and new variants emerging, authorised vaccines may need to be adapted, in time to ensure continued protection. Initial data indicates that some of these variants may have an impact on the level of protection provided by COVID-19 vaccines against infection and disease.

Therefore, it is an urgent public health priority to define an expedited regulatory process for the adaptation of vaccines to protect against current or future variants. There are ongoing discussions at international level on how to approach variants and vaccines in a coordinated way.

EMA’s human medicines committee (CHMP) has adopted a reflection paper which details the laboratory (non-clinical), clinical, quality and manufacturing data needed to support the approval of such ‘variant’ vaccines.

The assumption behind the CHMP’s guidance is that a new variant vaccine would largely rely on the same technology and platform as the ‘parent’ vaccine – a vaccine already approved in the EU for the prevention of COVID-19. The difference would be in the specific structure (antigen) selected to trigger the immune response in the body…
Reflection paper on the regulatory requirements for vaccines intended to provide protection against variant strain(s) of SARS-CoV-2 (PDF/240.55 KB) (new)

 

 

News: International cooperation to align approaches for regulation of COVID-19 vaccines and medicines
Last updated: 25/02/2021
Regulators around the globe are committed to aligning their regulatory requirements and addressing knowledge gaps to facilitate the development, authorisation and monitoring of safe, effective and high-quality vaccines and medicines against COVID-19. This was highlighted in a series of regulatory workshops, convened under the umbrella of the International Coalition of Medicines Regulatory Authorities (ICMRA) in the first weeks of 2021, which focused on three areas: responding to emerging COVID-19 virus variants, addressing knowledge gaps regarding COVID-19 vaccines and treatments in pregnant and breastfeeding women, and strengthening collaboration on safety monitoring of vaccines…

 

 

News: EMA starts rolling review of Celltrion antibody regdanvimab for COVID-19
Last updated: 24/02/2021

 

European Vaccine Initiative [to 27 Feb 2021]
http://www.euvaccine.eu/
Latest News
No new digest content identified.

 

FDA [to 27 Feb 2021]
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/default.htm
Press Announcements /Selected Details
February 26, 2021 – FDA Statement on Vaccines and Related Biological Products Advisory Committee Meeting
Following today’s positive advisory committee meeting outcome regarding the Janssen Biotech Inc. COVID-19 Vaccine, the U.S. Food and Drug Administration has informed the sponsor that it will rapidly work toward finalization and issuance of an emergency use authorization. The agency has also notified our federal partners involved in vaccine allocation and distribution so they can execute their plans for timely vaccine distribution…

February 26, 2021 – Coronavirus (COVID-19) Update: February 26, 2021

February 25, 2021 – Coronavirus (COVID-19) Update: FDA Allows More Flexible Storage, Transportation Conditions for Pfizer-BioNTech COVID-19 Vaccine

 

FDA – COVID-19 Vaccines [to 27 Feb 2021]
www.fda.gov/covid19vaccines
News and Updates; Upcoming Events
FDA Statement on Vaccines and Related Biological Products Advisory Committee Meeting
02/26/2021
Following today’s positive advisory committee meeting outcome regarding the Janssen Biotech Inc. COVID-19 Vaccine, the FDA has informed the sponsor that it will rapidly work toward finalization and issuance of an emergency use authorization.

 

Fondation Merieux [to 27 Feb 2021]
http://www.fondation-merieux.org/
News, Events
Mérieux Foundation co-organized event
MERACON: Returning to rabies elimination in 2021 webinar
February 26, 2021 – 9:00am -12:00pm (CET)
Context
The COVID-19 pandemic has hampered global travel and has placed a strain on public health systems globally. Because of this, many rabies activities were postponed or cancelled in 2020. Similarly, the planned in-person regional MERACON workshop that was initially scheduled for mid-2020 was postponed to 2021. As a means to continue remote support, foster collaboration and continue to drive progress towards rabies elimination in the MERACON countries, the MERACON steering committee has scheduled a digital meeting in webinar format. This webinar will act as a precursor to a more detailed workshop later in the year which we hope to host in-person (COVID-19 restrictions permitting).

 

Gavi [to 27 Feb 2021]
https://www.gavi.org/
News Releases
COVID-19 vaccine doses shipped by the COVAX Facility head to Ghana, marking beginning of global roll-out

No-fault compensation programme for COVID-19 vaccines is a world first
[See COVID above for detail on these announcements]

 

GHIT Fund [to 27 Feb 2021]
https://www.ghitfund.org/newsroom/press
GHIT was set up in 212 with the aim of developing new tools to tackle infectious diseases that
Press Releases
February 25, 2021
GHIT and EDCTP co-invest additional 7.8 million Euro in the Pediatric Praziquantel Consortium’s access program to ensure treatment of schistosomiasis for preschool-aged children

 

Global Fund [to 27 Feb 2021]
https://www.theglobalfund.org/en/news/
News & Stories
News
The Republic of the Congo and Global Fund Sign New Grants to Increase Access to HIV, TB and Malaria Prevention and Treatment
25 February 2021
The Global Fund, the Government of the Republic of the Congo and health partners launched the implementation of two new grants to strengthen prevention and treatment services to fight HIV, TB and malaria and build resilient and sustainable systems for health.

News
Burkina Faso and Global Fund Launch New Grants to Accelerate Progress against HIV, TB and Malaria
25 February 2021
The Government of Burkina Faso, the Global Fund and health partners strengthened their partnership by launching four new grants to accelerate the end of AIDS, tuberculosis and malaria as epidemics and strengthen health systems. The new grants will cover the 2021-2023 implementation period.

 

Global Research Collaboration for Infectious Disease Preparedness [GloPID-R] [to 27 Feb 2021]
https://www.glopid-r.org/news/
News
No new digest content identified.

 

Hilleman Laboratories [to 27 Feb 2021]
http://www.hillemanlabs.org/
No new digest content identified.

 

Human Vaccines Project [to 27 Feb 2021]
http://www.humanvaccinesproject.org/media/press-releases/
Press Releases
No new digest content identified.

 

IAVI [to 27 Feb 2021]
https://www.iavi.org/newsroom
PRESS RELEASES/FEATURES
No new digest content identified.

 

 

International Coalition of Medicines Regulatory Authorities [ICMRA]
http://www.icmra.info/drupal/en/news
Selected Statements, Press Releases, Research
No new digest content identified.

 

 

International Generic and Biosimilar Medicines Association [IGBA]
https://www.igbamedicines.org/
*News
Press Releases/Announcements
No new digest content identified.

 

 

IFFIm
http://www.iffim.org/
Press Releases/Announcements
No new digest content identified.

 

IFRC [to 27 Feb 2021]
http://media.ifrc.org/ifrc/news/press-releases/
Selected Press Releases, Announcements
No new digest content identified.

 

Institut Pasteur [to 27 Feb 2021]
https://www.pasteur.fr/en/press-area
Press release 26.02.2021
Covid-19: Keeping schools as safe as possible
A year into the pandemic, and confronted with continued resurgence in transmission, over 800 million schoolchildren, more than half the world’s student population, still face substantial disruptions to their education…
Read the full editorial in the BMJ

 

IRC International Rescue Committee [to 27 Feb 2021]
http://www.rescue.org/press-release-index
Media highlights [Selected]
No new digest content identified.

 

IVAC [to 27 Feb 2021]
https://www.jhsph.edu/research/centers-and-institutes/ivac/index.html
Updates; Events
No new digest content identified.

 

IVI [to 27 Feb 2021]
http://www.ivi.int/
Selected IVI News, Announcements, Events
George Bickerstaff re-elected Chairperson of the International Vaccine Institute’s Board of Trustees
February 22, 2021, SEOUL, Korea – The International Vaccine Institute (IVI) announced today that its Board of Trustees (BOT) re-elected Mr. George Bickerstaff as Chairperson of the BOT. His second three-year term will begin this May…

 

JEE Alliance [to 27 Feb 2021]
https://www.jeealliance.org/
Selected News and Events
No new digest content identified.

 

Johns Hopkins Center for Health Security [to 27 Feb 2021]
https://www.centerforhealthsecurity.org/news/center-news/
Center News
New Report: Crisis Standards of Care: Lessons from New York City Hospitals’ COVID-19 Experience: The Emergency Medicine Perspective
February 25, 2021

 

MSF/Médecins Sans Frontières [to 27 Feb 2021]
http://www.msf.org/
Latest [Selected Announcements]
DRC Ebola outbreaks
MSF responds in North Kivu to twelfth Ebola outbreak in DRC
Project Update 25 Feb 2021

 

National Vaccine Program Office – U.S. HHS [to 27 Feb 2021]
https://www.hhs.gov/vaccines/about/index.html
Upcoming Meetings/Latest Updates
No new digest content identified.

 

NIH [to 27 Feb 2021]
http://www.nih.gov/news-events/news-releases
News Releases
NIH study finds that people with SARS-CoV-2 antibodies may have a low risk of future infection
February 24, 2021 — Results may explain why reinfection appears to be relatively rare.

Monoclonal antibodies against MERS coronavirus show promise in Phase 1 NIH-sponsored trial
February 23, 2021 — Antibodies were well tolerated and generally safe when administered simultaneously to healthy adults.

 

UN OCHA [to 27 Feb 2021]
https://www.unocha.org/
Research
Global Humanitarian Response Plan COVID-19 Progress Report: Final Progress Report
OCHA 22 Feb 2021
PDF: https://reliefweb.int/sites/reliefweb.int/files/resources/GHRP_ProgressReport_22FEB.pdf
COVID-19 AND THE HUMANITARIAN LANDSCAPE
2020 was a year like no other. Amidst on-going humanitarian crises, largely fuelled by conflict and violence but also driven by the effects of climate change – such as the largest locust infestation in a generation – the world had to contend with a global pandemic. In less than one year (March-December 2020), more than 82 million COVID-19 cases and 1.8 million deaths were recorded. In that timeframe, out of the global COVID-19 totals, 30 per cent of COVID-19 cases and 39 per cent deaths were recorded in GHRP countries…

 

PATH [to 27 Feb 2021]
https://www.path.org/media-center/
Press Releases
No new digest content identified.

 

Sabin Vaccine Institute [to 27 Feb 2021]
http://www.sabin.org/updates/pressreleases
Statements and Press Releases
No new digest content identified.

 

UNAIDS [to 27 Feb 2021]
http://www.unaids.org/en
Selected Press Releases/Reports/Statements
25 February 2021
COVID-19 spurs on multimonth dispensing of HIV treatment in Cambodia

 

UNHCR Office of the United Nations High Commissioner for Refugees [to 27 Feb 2021]
http://www.unhcr.org/en-us/media-centre.htmlS
Selected Announcements
No new digest content identified.

 

UNICEF [to 27 Feb 2021]
https://www.unicef.org/media/press-releases
Selected Press releases, Statements
Press release
02/26/2021
Latter-day Saint Charities commits US$20 million in support of UNICEF’s global COVID-19 response
Latter-day Saint Charities becomes the single largest private sector donor to date to support UNICEF’s ACT-Accelerator and COVAX work

Press release
02/26/2021
Côte d’Ivoire becomes second African country and first French-speaking country to receive vaccine doses via COVAX Facility

News note
02/25/2021
UNICEF signs COVID-19 vaccine supply agreement with AstraZeneca

Press release
02/24/2021
COVID-19 vaccine doses shipped by the COVAX Facility head to Ghana, marking beginning of global rollout

Statement
02/24/2021
Ghana becomes recipient of historic first shipment of COVAX vaccine
Statement by UNICEF Representative in Ghana, Anne-Claire Dufay and WHO Representative to Ghana, Dr Francis Kasolo on the arrival of the first COVID-19 vaccines in Accra

 

Unitaid [to 27 Feb 2021]
https://unitaid.org/
Featured News
25 February 2021
COVID-19 oxygen emergency impacting more than half a million people in low- and middle-income countries every day, as demand surges
:: More than half a million COVID-19 patients in LMICs estimated to need oxygen treatment every day.
:: New assessments show US$90 million immediate funding required to meet urgent need in up to 20 low- and middle-income countries (LMICs). Unitaid and Wellcome will make an immediate contribution of up to US$20 million in total for the emergency response.
:: COVID-19 Oxygen Emergency Taskforce brings together key organisations working on oxygen access under ACT-Accelerator Therapeutics pillar, as COVID-19 surges and preventable deaths occur
:: Taskforce partners will work together to measure oxygen demand, work with financing partners, and secure oxygen supplies and technical support for worst-affected countries

 

Vaccination Acceptance Research Network (VARN) [to 27 Feb 2021]
https://vaccineacceptance.org/news.html#header1-2r
Announcements
No new digest content identified.

 

Vaccine Confidence Project [to 27 Feb 2021]
http://www.vaccineconfidence.org/
News, Research and Reports
No new digest content identified.

 

Vaccine Education Center – Children’s Hospital of Philadelphia [to 27 Feb 2021]
http://www.chop.edu/centers-programs/vaccine-education-center
News
Vaccine Update for Providers = February 2021

 

Wellcome Trust [to 27 Feb 2021]
https://wellcome.ac.uk/news
Opinion
COVAX campaign for equitable vaccine access delivers first doses to West Africa
The largest mass vaccination campaign in history has begun. Ghana and Cote D’Ivoire have become the first countries to receive Covid-19 vaccines through COVAX. Richard Hatchett, CEO at the Coalition for Epidemic Preparedness Innovations (CEPI), the vaccine research and development partnership co-leading COVAX, reacts to this historic moment.
25 February 2021

 

The Wistar Institute [to 27 Feb 2021]
https://www.wistar.org/news/press-releases
Press Releases
No new digest content identified.

 

WFPHA: World Federation of Public Health Associations [to 27 Feb 2021]
https://www.wfpha.org/
Latest News
Operation Vaccination: An Analysis of Global COVID-19 Vaccine Rollout Strategies is a weekly post which will explore the policy, logistics, obstacles and controversies involved in procuring and distributing vaccines against COVID-19.
The theme of this week is “Communication and Trust: Keeping the Public Informed and On Board”.
Focusing on the 9 countries featured in this blog (Brazil, India, Indonesia, Ireland, Israel, Nigeria, Taiwan, UK, US) and COVAX, communication strategies are analysed, focusing on mitigating vaccine hesitancy and explanations of the structure and timing of immunization drives..

 

World Bank [to 27 Feb 2021]
http://www.worldbank.org/en/news/all
Selected News, Announcements
IDA’s COVID-19 Response: Speed, Scale and Selectivity
Since the beginning of the COVID-19 pandemic, IDA has provided substantial support to IDA countries’ crisis response and development programs, helping them transition to a resilient and…
Date: February 23, 2021 Type: Infographic [full image at title link]
[The International Development Association (IDA) is the part of the World Bank that helps the world’s poorest countries. Overseen by 173 shareholder nations, IDA aims to reduce poverty by providing zero to low-interest loans (called “credits”) and grants for programs that boost economic growth, reduce inequalities, and improve people’s living conditions.]

 

World Organisation for Animal Health (OIE) [to 27 Feb 2021]
https://www.oie.int/en/for-the-media/press-releases/2021/
Press Releases
No new digest content identified.

 

 

::::::

 

ARM [Alliance for Regenerative Medicine] [to 27 Feb 2021]
Press Releases – Alliance for Regenerative Medicine (alliancerm.org)
Press Releases
No new digest content identified.

 

BIO [to 27 Feb 2021]
https://www.bio.org/press-releases
Press Releases
No new digest content identified.

 

DCVMN – Developing Country Vaccine Manufacturers Network [to 27 Feb 2021]
http://www.dcvmn.org/
News; Upcoming events
No new digest content identified.

 

ICBA – International Council of Biotechnology Associations [to 27 Feb 2021]
https://internationalbiotech.org/news/
News
No new digest content identified.

 

IFPMA [to 27 Feb 2021]
http://www.ifpma.org/resources/news-releases/
Selected Press Releases, Statements, Publications
No new digest content identified.

 

PhRMA [to 27 Feb 2021]
http://www.phrma.org/
Selected Press Releases, Statements
Coming together to fight COVID-19: A conversation with Paul Perreault, CEO and Managing Director of CSL
February 24, 2021
This year, our industry has been working around the clock to combat the COVID-19 virus, including developing effective therapeutics to treat COVID-19 and vaccines to prevent future infections. I had the opportunity to connect with Paul Perreault, CEO and Managing Director of CSL Limited, the world’s third largest biotech, about the company’s efforts to address COVID-19.
Blog Post

ICYMI: Report provides actional recommendations to strengthen America’s preparedness and future health crises response
February 22, 2021
As America’s biopharmaceutical researchers continue working around the clock to fight COVID-19, leaders in the health care ecosystem have come together to provide recommendations to strengthen America’s preparedness and future health care crises response…
The report provides a comprehensive set of recommendations to improve the nation’s capabilities for disaster preparedness and response. The recommendations include:
:: Creation by the White House of a standing disaster preparedness group that will include private sector expertise in areas such as production capacity, supply chain and distribution, and acute care delivery.
:: Modernizing the health care supply chain through digitalization, automation, and predictive analytics, with standardized approaches for allocating resources based on need and equity to prevent bidding wars between states and healthcare providers.
:: Improving supply chain resilience with strategic incentives such as zero percent loans, federally-guaranteed purchase commitments, and geographic diversification of production for critical medical products.
:: Construction of a 21st century public health early warning system that will utilize all available electronic health records and public health data collection.
:: Legislation and regulatory reform to create rapid response capabilities in areas such as medical licensure portability, telehealth accessibility, and swift access to PPE stockpiles.
:: Creation of measures to ensure health equity and address disparities, identifying high-risk vulnerable populations and directing resources accordingly.
Blog Post